I just noticed that two days ago, the maximum age of those in the study was raised from 75 to 85. Some dialogue must have transpired between the FDA and Insmed regarding NTM right around the time that Lewis practically called this phase II trial a phase III in disguise.
That's significant. It can become very clear in a short period of time how well the antibiotic is working even if it's up against the placebo. The placebo candidates get put on the real thing after the first phase of treatment anyway, if I'm not mistaken. Insmed's star is rising!!!